文献速递先天性心脏病外科

理解先天性心脏病手术后死亡风险:手术特异性因素能增加什么信息

Understanding Mortality After Congenital Heart Surgery: What Do Procedure-Specific Factors Add?
PubMed 文献 · Ann Thorac Surg · 2025-10-21

本研究基于美国115个中心2016至2022年的基准手术数据,评估手术特异性因素(PSF)对预测死亡风险的贡献。在37,282例基准手术中,总体手术死亡率为2.6%,将PSF纳入模型后整体区分度从0.088提升至0.095,9种基准手术中有5种区分度改善。不同PSF的影响因手术类型和分析方法而异,部分PSF对死亡估计有重要影响,而另一些则无。

要点

  • 将PSF纳入预期死亡模型可改善部分基准手术的风险区分度。
  • PSF记录比例从室间隔缺损的2.7%到Norwood手术的85%不等。
  • Norwood和动脉干修复保留的PSF数量最多,室间隔缺损无PSF保留。

核心结论

  • 将PSF纳入预期死亡模型可改善部分基准手术的模型区分度,某些PSF对死亡估计有重要影响,而另一些则无。

研究设计与样本

  • 回顾性队列研究,纳入美国115个中心2016至2022年记录的基准手术(BMO),共37,282例。
  • 采用高级建模策略比较基线模型(含标准STS-CHSD临床风险变量)与基线加PSF模型,整体及按BMO分层报告结果。

主要发现

  • 总体手术死亡率为2.6%。
  • 至少记录1项PSF的BMO比例从室间隔缺损的2.7%到Norwood的85%不等。
  • 模型区分度整体从基线0.088提升至基线加PSF的0.095,9种BMO中有5种区分度更好。
  • 不同PSF的影响因BMO和分析方法而异,室间隔缺损在所有情景下最终模型均未保留PSF,Norwood和动脉干修复保留的PSF数量最多。

临床怎么用

  • 研究结果可帮助减少数据收集负担,并支持风险模型的持续优化。
  • 临床可参考PSF对特定基准手术死亡风险预测的附加价值,但需注意其影响因手术类型而异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although collected by The Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) since 2013, the value of procedure-specific factors (PSFs) in improving our understanding of expected mortality has not been studied. We evaluated the contribution of PSFs across a large cohort. METHODS: Included were benchmark operations (BMO) for which PSFs are captured across 115 United States centers (2016-2022). We assessed the influence of PSFs on operative mortality discrimination and determined which specific PSFs had the most impact. Advanced modeling strategies were used given the numerous covariates and relatively low mortality rates. A baseline model (including standard STS-CHSD clinical risk variables) was compared with a baseline plus PSF model, with results reported overall and stratified by BMO. RESULTS: Among 37,282 included BMOs, overall operative mortality was 2.6%. The proportion of BMOs with at least 1 PSF recorded as present ranged from 2.7% for ventricular septal defect to 85% for Norwood. Model discrimination increased from 0.088 (baseline) to 0.095 (baseline + PSF) overall, with better discrimination for 5 of 9 BMOs. Results for individual PSFs varied by BMO and analytic method. No PSFs were retained in the final models for ventricular septal defect in any scenario. The greatest number of PSFs were retained for Norwood and truncus arterious repair. CONCLUSIONS: Incorporating PSFs into expected mortality models improved model discrimination for some BMOs, and certain PSFs had an important impact on mortality estimates, whereas others did not. These data can aid in reducing data collection burden and support ongoing refinement of risk models.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Nathan M, Han L, Zelevinsky K, et al. Understanding Mortality After Congenital Heart Surgery: What Do Procedure-Specific Factors Add? Ann Thorac Surg. 2025. PMID: 41130537. doi:10.1016/j.athoracsur.2025.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。